InvestorsHub Logo

EichKing

11/15/17 10:26 AM

#8235 RE: Scott999 #8231

Scott.......we are wasting our time on here...just like the Yahoo board. The way I understand it, the IC trials showed good safety profile and they "observed" an improvement from an efficacy standpoint, thus they got the grant money from Europe to move forward. Further, CLI is the deterioration of IC, which tends to lead to amputation of the limb and/or death. I also read they expect data from the trial in H1 18, meaning by June. Drip Drip...$1.38